PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08

Reported: July 12, 2023 Initiated: June 26, 2023 #D-0895-2023

Product Description

Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08

Reason for Recall

Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Details

Recalling Firm
Strides Pharma Inc.
Units Affected
2,700 HDPE Bottles
Distribution
Nationwide in the USA.
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08. Recalled by Strides Pharma Inc.. Units affected: 2,700 HDPE Bottles.
Why was this product recalled?
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 12, 2023. Severity: Moderate. Recall number: D-0895-2023.